Key facts
- It has raised $2.8M; the latest was Seed Round ($2.1M) in Mar 2026.
- Notable investors include Blume Venture Advisors, Kunal Shah, All In Capital, Bharat Founders Fund, Panasonic Ignition — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Mave (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Mave (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mave (Therapeutic Devices)
Developer of a wearable headset device designed to treat depression. The company offers a non-invasive brain stimulation (NIBS) wearable device created based on neuro-technologies along with a personalized program that includes physical fitness, therapy, nutrition diet, and coaching, enabling customers to improve brain health and treat depression without any side effects.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2023
- Employees
- 30
- Website
- mavehealth.com/
- Ownership
- Privately Held (backing)
Mave (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mave (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mave (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.